Gordon Findlay, an executive at Novo Nordisk, collapsed in the Oval Office on Thursday afternoon while President Trump was announcing a plan to reduce the price of weight-loss drugs, including Ozempic. Findlay received medical assistance on site and has been reported to be expected to recover fully.
“Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic.”
The announcement focused on lowering the cost of weight-loss medications, which has drawn significant public attention.
Summary: Novo Nordisk executive Gordon Findlay collapsed during President Trump's announcement on reducing weight-loss drug prices but received timely medical aid and is expected to recover fully.